Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-response study of liposomal bupivacaine in serratus anterior plane block for thoracoscopic pulmonary wedge resection
ChiCTR2600134575Phase 4Recruiting
- Sponsor
- Yan'an University Affiliated Hospital
- Start
- Dec 2025
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of liposomal bupivacaine in postoperative pain, sponsored by Yan'an University Affiliated Hospital. Primary endpoint: Time to first request for rescue analgesia. Started Dec 2025; status: recruiting.
02
Drugs
liposomal bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2600134575.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600134575.